BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2014
View Archived Issues
hAT-MSCs partially restore corneal epithelial phenotype in an in vivo model of LSCD
Read More
Temozolomide causes biological and radiological improvements in pituitary carcinoma case study
Read More
Sanofi creates hybrid VEGF/PDGF soluble receptors for AMD
Read More
Novel bispecific antibody for the treatment of P. aeruginosa infection
Read More
Close-field electroporation gene delivery for damaged cochlear hair cells regeneration
Read More
Discovery of a unique bacterial zinc metalloprotease inhibitor
Read More
Beraprost sodium single isomer shows potential for influenza
Read More
KinoPharma and Carna Biosciences patent new DYRK1A inhibitors
Read More
Researchers at Zafgen design novel MetAP 2 inhibitors for obesity
Read More
Allergan reports discovery of S1P1 receptor ligands
Read More
Bristol-Myers Squibb and CytomX Therapeutics establish immune-oncology collaboration
Read More
BioCryst reports preliminary results from OPuS-1 study of BCX-4161 for HAE
Read More
Spark Therapeutics completes Series B financing
Read More
Novogen identifies compounds active against prostate cancer cells
Read More
Roche licenses rights to antibody engineering technologies from Chugai
Read More
MacroGenics and Takeda Pharmaceutical enter into option agreement for MGD-010
Read More
RaQualia Pharma researchers prepare and test Na channel blockers
Read More
U.S. investigators report development of HDAC inhibitors for AKI
Read More
TetraLogic selects phase II dose of birinapant for higher risk MDS
Read More
BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer
Read More
Enrollment under way in phase I study of MEDI-7510 for RSV
Read More
European approval for Entyvio in ulcerative colitis and Crohn's disease
Read More
Xarelto filed in Japan for three indications
Read More
Valeant makes revised proposal to Allergan, plans to sell filler and toxin assets to Nestle
Read More
FDA grants fast track designation to obeticholic acid for primary biliary cirrhosis
Read More